Company intelligence / Profile preview

Shanghai HuaGene Biotech

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

HuaGene (Shanghai) Biotech is a synthetic biology company specializing in high-throughput DNA and RNA synthesis technologies. The company provides a comprehensive suite of services including gene synthesis, oligonucleotide synthesis, next-generation sequencing (NGS), and peptide synthesis to support life science research and drug development. HuaGene leverages its proprietary synthesis platforms to deliver customized molecular biology solutions for academic, clinical, and industrial partners. By integrating advanced bioinformatics with automated manufacturing, the company facilitates the rapid development of genetic tools and therapeutic precursors.

Modalities: Synthetic DNASynthetic RNAPeptidesBiologic
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Shanghai HuaGene Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai HuaGene Biotech.

Explore the full profile